Why is Pareidolia More Common in Parkinson's Disease?

Posted on Sep 8, 2024

Table of contents:

Pareidolia manifests differently in patients with Parkinson’s disease (PD) compared to those with multiple system atrophy (MSA), primarily in terms of prevalence and the underlying cognitive and neural mechanisms.

Prevalence of Pareidolia

Higher Incidence in Parkinson’s Disease: Research indicates that pareidolia is significantly more common in patients with Parkinson’s disease. In a study, 47.5% of PD patients exhibited pareidolic responses, while only 18.8% of MSA patients did so. This difference is statistically significant (P=0.001), suggesting that pareidolia is a more prominent feature in PD than in MSA.
Absence of Visual Hallucinations: Notably, the study found that none of the subjects in either group experienced visual hallucinations, indicating that pareidolia in these patients occurs independently of more severe visual disturbances.

Cognitive and Emotional Factors

Anxiety Correlation: Among PD patients who experience pareidolia, there is a notable correlation with higher levels of anxiety. Those with pareidolic responses scored higher on the State-Trait Anxiety Inventory, which suggests that emotional factors may play a role in the experience of pareidolia in PD.
Neuropsychological Differences: The cognitive profiles of PD patients with pareidolia may differ from those without it, although specific neuropsychological test results were not detailed in the findings. This indicates that pareidolia could be linked to cognitive changes associated with PD progression.

Neural Mechanisms

Functional Connectivity: Studies have shown that patients with PD who experience pareidolia exhibit decreased functional connectivity in the frontotemporal lobes, which are critical for face recognition and processing. This impairment may contribute to the heightened experience of pareidolia.
Contrast with MSA: In MSA, the lower prevalence of pareidolia might suggest that the neural pathways or cognitive processes involved in pattern recognition differ from those in PD. The specific mechanisms that lead to pareidolia in MSA patients remain less understood, indicating a need for further research to clarify these differences.

Conclusion

In summary, pareidolia is more prevalent in Parkinson’s disease than in multiple system atrophy, with significant implications for understanding the cognitive and emotional landscape of these conditions. The association of pareidolia with anxiety in PD patients and the differences in neural connectivity highlight the complex interplay between neurological health and perceptual experiences.

Citations: